. Author manuscript; available in PMC: 2023 Nov 2.

Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2023 Nov 1;32(11):1591–1598. doi: 10.1158/1055-9965.EPI-23-0066

Table 2.

Observed (March 2020 – February 2021) vs. Expected (March 2020 – February 2021) Pathology Report Volume in 11 SEER Registries.

		Biopsy		Surgical		Cytology		Molecular/Biomarkers		Other^b		Total
		Observed	O/E	Observed	O/E	Observed	O/E	Observed	O/E	Observed	O/E	Observed	O/E
Sex	Male	173341	0.93 ^*	52346	0.89 ^*	37346	0.97 ^*	6564	1.07 ^*	46821	0.99	316418	0.94 ^*
Sex	Female	243046	0.89 ^*	84516	0.89 ^*	40518	0.96 ^*	14677	1.01	39912	0.92 ^*	422669	0.90 ^*
Age (Yrs.)	< 50	62712	0.92 ^*	26985	0.89 ^*	11935	0.92 ^*	4126	1.05 ^*	17165	0.96 ^*	122923	0.93 ^*
	50–64	135240	0.91 ^*	48469	0.89 ^*	23294	0.99	7050	1.09 ^*	25024	0.95 ^*	239077	0.92 ^*
	65–74	127446	0.90 ^*	39174	0.89 ^*	23052	0.97 ^*	5869	0.98	25402	0.98	220943	0.91 ^*
	≥ 75	90989	0.90 ^*	22234	0.90 ^*	19583	0.94 ^*	4196	0.97	19142	0.92 ^*	156144	0.91 ^*
Primary Site	Colorectal	28740	0.89 ^*	22307	0.92 ^*	1427	1.15 ^*	1809	1.10 ^*	414	0.86 ^*	54697	0.91 ^*
	Female Breast	120974	0.88 ^*	31024	0.89 ^*	5063	0.96	8228	1.01	6484	0.82 ^*	171773	0.88 ^*
	Lung	38321	0.87 ^*	9425	0.80 ^*	23838	0.95 ^*	2996	1.26 ^*	634	0.72 ^*	75214	0.89 ^*
	Melanoma	41327	0.85 ^*	807	0.99	885	0.94	193	1.36 ^*	286	2.38 ^*	43498	0.86 ^*
	Prostate	40044	0.90 ^*	10536	0.87 ^*	359	0.95	191	4.44 ^*	242	0.72 ^*	51372	0.90 ^*
	All Others^a	146981	0.96 ^*	62763	0.90 ^*	46292	0.96 ^*	7824	1.02	78673	0.98 ^*	342533	0.95 ^*

(p<0.05)

– All other cancer sites reportable to cancer registries

– Other report type includes blood/bone marrow/flow cytometry, autopsy, and none of the above